Kursad Turksen’s Post

Trial of Lixisenatide in Early Parkinson’s Disease https://lnkd.in/e5NbZ4ps

Are you dealing with Fungal Sinusitis? This is an inflammation or infection of the sinuses caused by fungi, and there are many different types. Learn more about \{hashtag\|\\\#\|fungalsinusitis\} and the treatment options for this serious condition.

Are you dealing with Fungal Sinusitis? This is an inflammation or infection of the sinuses caused by fungi, and there are many different types. Learn more about {hashtag|\#|fungalsinusitis} and the treatment options for this serious condition.

Are you dealing with Fungal Sinusitis? This is an inflammation or infection of the sinuses caused by fungi, and there are many different types. Learn more about {hashtag|\#|fungal sinusitis } and the treatment options for this serious condition.

Are you dealing with Fungal Sinusitis? This is an inflammation or infection of the sinuses caused by fungi, and there are many different types. Learn more about \{hashtag\|\\\#\|fungal sinusitis \} and the treatment options for this serious condition.

Eric Topol has just released an excellent new podcast: "Pradeep Natarajan: Preventing Heart Disease". Drs. Natarajan and Topol review new tests, drugs, and approaches that can help reduce the risk of future cardiovascular disease. https://lnkd.in/gky4Kn8k They nicely alternate among the basic physiology and genetics, the epidemiology and epistemology, and the clinical evidence and art. I found the discussions of Lp(a) and its treatment with newer pharmaceuticals such as PCSK9 inhibitors and other drugs still under investigation for potential approval especially edifying. Kudos to Drs. Pradeep Natarajan and Eric Topol, MD! Some who may be interested or wish to comment include: Robert Considine, Nir Barzilai, Louis Aronne, Caroline Apovian, Robert Eckel, Steven Heymsfield, Arne Astrup, Blandine Laferrere, Frank Greenway, Richard Deckelbaum MD,CM, FRCP(C), MICHAEL MIRRO, Lawrence Rink, David Hormuth, MD, MBA, Donna Ryan, Sam Chai, Ph.D., John Sievenpiper, MD, PhD, FRCPC, Jamy Ard.

World Mitochondrial Disease Week continues 💚 It is estimated that about 1 in 5,000 people today live with mitochondrial disease, a severe and debilitating disease that often affects many of the organ systems. Several measures have been taken to facilitate drug development in rare disease (e.g. the Orphan Drug Act), but there are no approved medicines for systemic mitochondrial disease. Our NV354 is being developed for mitochondrial disease with neurologic complications, including Leigh syndrome - a devastating mitochondrial disease affecting children in their first years of life. Listen to our CSO, Eskil Elmér, and researcher, Imen Chamkha, talking about how our journey in mitochondrial disease drug development began, how we can measure mitochondrial function, and our NV354 program. #WorldMitoWeek2024 #IlluminateTomorrow #raredisease #patientsfirst #leighsyndrome #drugdevelopment #mitochondrialphysiology #oroborosinstruments https://lnkd.in/ddxgZmh6

If you suffer from constant abdominal pain, weight loss and diarrhea, you could have celiac disease. In this article, Bottom Line expert Suneeta Krishnareddy, MD, discusses the symptoms, causes, diagnoses and remedies.

Morning catch-up read on all things deubiquitinating enzymes & E3 ubiquitin ligases in Parkinson’s disease. https://lnkd.in/eiXgK-HZ #DUBs #E3ligases #ubiquitin #proteasome #ParkinsonsDisease

The Link Between Proteins, Alzheimer’s and Parkinson’s Diseases; "Proteins are large biomolecules that play critical roles in a host of cellular processes, from cell signaling to regulating the immune system. However, these life-giving proteins can form toxic aggregate species that have been linked to several neurodegenerative diseases, including Alzheimer’s Disease and Parkinson’s Disease. In this program, UC Santa Barbara professor Joan-Emma Shea discusses the tau protein as a model system to study neurodegeneration. Shea says this protein plays a functional role in stabilizing microtubules in brain cells, but it can also self-assemble to form amyloid fibrils (large “clumps” of Tau proteins). There are several neurodegenerative diseases linked to tau assembly, including Alzheimer’s Disease, Pick’s Disease, and chronic traumatic encephalopathy, and they are collectively known as tauopathies. Shea discusses new insights into tauopathies and targets for therapeutics. Recorded on 06/26/2024."; Oct 18, 2024; University of California Television: https://lnkd.in/ez8c2ZcB